We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A baby laying down.

No Adverse Health Risks From Steroids Used for Pre-Term Birth, Study Finds

A ginger haired woman leaning over the arm of a chair.

Scientists Identify Brain Circuit That Suppresses Appetite During Nausea

Immunotherapy attacking a cancer cell.

Immunotherapy Combination Approved for Non-Muscle Invasive Bladder Cancer

Psilocybin Shows Promise for Treatment-Resistant Depression – But Is It Safe?

Phage Therapies for Multidrug-Resistant Infections Should Consider Host Response

First Use of CRISPR-Cas9 Gene Editing in Kissing Bugs

News

MGB Biopharma Continues to Progress its Truly Novel Anti-Infectives Platform

Oral formulation of MGB-BP-3 for the treatment of Clostridium difficile infections on track to enter the clinic in Q2 2015.

Radleys Launch New Website

The site help customers understand Company’s complete range of chemistry productivity tools.

Rosetta Genomics Launch Admera’s Sequencing-Based Oncology Tests

The tests will help to predict patient’ responses to drugs based on their personal genetic makeup.

XRpro Sciences Announces Completion of Equity Financing

The equity financing will contribute towards the growth of XRpro’s ion channel drug development technology.

Proteros Enters into a Collaboration with Bayer

Collaboration to develop new cardiovascular drug compounds for an integral membrane protein.

AMRI To Acquire Aptuit Drug Product Development Businesses

Significantly expands AMRI's analytical services capabilities and extends drug product development services to include sterile injectable formulation development.

Antriabio Announces Completion Of PK/PD Studies Of AB101

AB101 positioned to be the first once-weekly basal insulin for diabetes patients.

Evotec and Padlock Therapeutics Extend Collaboration

Evotec and Padlock Therapeutics announce initial success and extension of long-term collaboration.

Isarna Therapeutics Unveils New Selective TGF-beta Antagonist Program

First-in-human study in advanced-stage glaucoma to begin in 1H2015.

Magnus Life Science Announces Recommendation for Orphan Designation

EMA’s Committee for Orphan Medicinal Products recommends Magnus growth therapy for placental insufficiency for orphan designation.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter